Cytoskeleton involvement in lithium-induced SH-SY5Y neuritogenesis and the role of glycogen synthase kinase 3β

被引:0
作者
Riadh Nciri
Mohamed Ali Boujbiha
Samira Jbahi
Mohamed Salah Allagui
Abdelfattah Elfeki
Christian Vincent
Françoise Croute
机构
[1] Universite Paul Sabatier Toulouse III,Laboratoire de Biologie Cellulaire, Faculté de Médecine Purpan
[2] Faculté des Sciences de Sfax,Laboratoire d’Ecophysiologie Animale
来源
Aging Clinical and Experimental Research | 2015年 / 27卷
关键词
Lithium; Cytoskeleton; Neuritogenesis; GSK3;
D O I
暂无
中图分类号
学科分类号
摘要
Lithium modulates signals impacting on the cytoskeleton, a dynamic system contributing to neural plasticity at multiple levels. In this study, SH-SY5Y human neuronal cells were cultured in the absence (C) or in presence (Li) of a 0.5 mM Li2CO3 (i.e. 1 mM lithium ion) for 25–50 weeks. We investigated the effect of this treatment on (1) morphological changes of cells observed using Hemalun eosin staining assay, (2) cytoskeletal changes by indirect immunofluorescence (IIF) staining of microtubules (α-tubulin) and heavy neurofilaments subunits (NF-H) and by measuring the expression rate changes of genes coding for receptor for activated C kinase (RACK1), casein kinase2 (CK2) and thymosine beta-10 using cDNA arrays technology, (3) cell adhesion properties by IIF staining of β-catenin protein. Besides, we have tried to understand the molecular mechanism of lithium action that triggers changes in cytoskeleton and neurites outgrowth. Thus, we examined the effect of this treatment on glycogen synthase kinase 3 (GSK3) expression and activity using western blotting of GSK3 and phosphorylated β-catenin, a downstream GSK3 target protein. Our results showed that lithium treatment reduces axon length, increases axonal spreading, enhances neurites growth and neurites branching with an increase of growth cone size. Moreover, genes coding for CK2 and thymosine beta-10 were significantly up-regulated, however, that coding for RACK1 was down-regulated. The most interesting result in this work is that mechanism underlying lithium action was not related to the inhibition of GSK3 activity. In fact, neither expression rate nor activity of this protein was changed.
引用
收藏
页码:255 / 263
页数:8
相关论文
共 164 条
[1]  
Beal MF(1995)Aging, energy, and oxidative stress in neurodegenerative disorders Ann Neurol 38 357-366
[2]  
Harman D(1998)Aging: phenomena and theories Ann NY Acad Sci 854 1-7
[3]  
Behl C(1999)Alzheimer’s disease and oxidative stress: implications for novel therapeutic approaches Prog Neurobiol 57 301-323
[4]  
Selkoe DJ(2001)Alzheimer’s disease: genes, proteins, and therapy Physiol Rev 81 741-766
[5]  
Annaert W(2002)A cell biological perspective on Alzheimer’s disease Annu Rev Cell Dev Biol 18 25-51
[6]  
De Strooper B(2011)Neuroprotective and neurotrophic effects of long term lithium treatment in mouse brain Biometals 24 747-757
[7]  
Riadh Nciri(2010)Novel insights into lithium’s mechanism of action: neurotrophic and neuroprotective effects Neuropsychobiology 62 50-60
[8]  
Allagui Mohamed Salah(2011)Differential display RT-PCR reveals genes associated with lithium-induced neuritogenesis in SK-N-MC cells Cell Mol Neurobiol 31 1021-1026
[9]  
Bourogaa Ezzedine(1999)Different mechanisms of protection against apoptosis by valproate and Li+ Eur J Biochem 266 886-891
[10]  
Vincent Christian(2003)International Group for the Study of Lithium Treated Patients (IGSLI). Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders Pharmacopsychiatry 36 250-254